Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 9 studies | 21% ± 6% | |
naive B cell | 7 studies | 19% ± 4% | |
B cell | 4 studies | 24% ± 4% | |
dendritic cell | 4 studies | 22% ± 4% | |
epithelial cell | 4 studies | 35% ± 23% | |
pericyte | 4 studies | 18% ± 1% | |
glutamatergic neuron | 4 studies | 33% ± 8% | |
T cell | 3 studies | 22% ± 7% | |
natural killer cell | 3 studies | 23% ± 5% | |
T follicular helper cell | 3 studies | 20% ± 5% | |
luminal cell of prostate epithelium | 3 studies | 17% ± 3% | |
GABAergic neuron | 3 studies | 20% ± 4% | |
plasmacytoid dendritic cell | 3 studies | 22% ± 5% | |
astrocyte | 3 studies | 23% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 23% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 3172.42 | 245 / 245 | 100% | 47.66 | 502 / 502 |
ovary | 100% | 2783.71 | 180 / 180 | 100% | 19.84 | 428 / 430 |
brain | 100% | 1424.64 | 2635 / 2642 | 99% | 15.78 | 700 / 705 |
thymus | 100% | 1993.38 | 653 / 653 | 98% | 13.60 | 593 / 605 |
kidney | 100% | 1733.37 | 89 / 89 | 97% | 14.05 | 872 / 901 |
breast | 100% | 2300.41 | 459 / 459 | 97% | 19.83 | 1079 / 1118 |
adrenal gland | 100% | 1565.52 | 258 / 258 | 93% | 7.84 | 214 / 230 |
pancreas | 100% | 1073.71 | 327 / 328 | 93% | 8.48 | 165 / 178 |
liver | 100% | 1477.38 | 226 / 226 | 92% | 8.54 | 373 / 406 |
skin | 97% | 857.65 | 1749 / 1809 | 93% | 15.75 | 437 / 472 |
lung | 100% | 2194.56 | 576 / 578 | 90% | 11.32 | 1034 / 1155 |
bladder | 100% | 1945.29 | 21 / 21 | 83% | 8.65 | 417 / 504 |
intestine | 98% | 1704.26 | 949 / 966 | 78% | 7.90 | 413 / 527 |
stomach | 100% | 1310.79 | 359 / 359 | 74% | 8.77 | 212 / 286 |
uterus | 100% | 2871.99 | 170 / 170 | 67% | 7.84 | 308 / 459 |
esophagus | 85% | 1423.78 | 1225 / 1445 | 73% | 8.30 | 133 / 183 |
adipose | 100% | 2309.18 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3363.60 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1260.81 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.23 | 1 / 1 |
muscle | 100% | 1415.99 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 100% | 1419.17 | 858 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 19.51 | 75 / 80 |
tonsil | 0% | 0 | 0 / 0 | 60% | 4.41 | 27 / 45 |
lymph node | 0% | 0 | 0 / 0 | 59% | 3.41 | 17 / 29 |
peripheral blood | 35% | 306.64 | 324 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0042162 | Molecular function | telomeric DNA binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZBTB10 |
Protein name | Zinc finger and BTB domain-containing protein 10 (Zinc finger protein RIN ZF) ZBTB10 protein |
Synonyms | RINZF RINZFC |
Description | FUNCTION: May be involved in transcriptional regulation. |
Accessions | A8E4L4 ENST00000426744.5 [Q96DT7-2] Q96DT7 ENST00000455036.8 [Q96DT7-1] ENST00000379091.8 [Q96DT7-4] ENST00000430430.5 [Q96DT7-1] |